Detalhe da pesquisa
1.
Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy.
J Gene Med
; 14(3): 151-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22262303
2.
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.
Arthritis Rheum
; 63(1): 84-95, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20967853
3.
Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity.
J Immunol
; 184(2): 824-35, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20018624
4.
HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.
J Virol
; 84(11): 5627-36, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20237085
5.
Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.
Mol Ther
; 17(9): 1643-50, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19584812
6.
Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2.
Cancer Lett
; 229(2): 271-81, 2005 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-16135400
7.
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.
Oncotarget
; 5(17): 7843-57, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25151659
8.
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?
Oncoimmunology
; 2(10): e26148, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244902
9.
Immune modulation by genetic modification of dendritic cells with lentiviral vectors.
Virus Res
; 176(1-2): 1-15, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23726846
10.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
J Exp Med
; 210(9): 1695-710, 2013 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23897981
11.
Selective activation of intracellular signalling pathways in dendritic cells for cancer immunotherapy.
Anticancer Agents Med Chem
; 12(1): 29-39, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21707504
12.
PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy.
Oncoimmunology
; 1(1): 86-88, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318430
13.
Targeting lentiviral vectors for cancer immunotherapy.
Curr Cancer Ther Rev
; 7(4): 248-260, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22983382
14.
On the Mechanism of T cell receptor down-modulation and its physiological significance.
J Biosci Med
; 1(1)2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318485
15.
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells.
EMBO Mol Med
; 3(10): 581-92, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21739608